chronic lymphocytic lymphoma

chronic lymphocytic lymphoma

a type of low-grade non-Hodgkin lymphoma characterized by lymphocytosis, lymphadenopathy, and, in late stages, hepatosplenomegaly; may be associated with chronic lymphocytic leukemia.
References in periodicals archive ?
Food and Drug Administration (FDA) for the treatment of chronic lymphocytic lymphoma (CLL) in patients who have received at least one prior therapy.
Additionally, in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, a polyclonal increase in the serum FLC concentration was associated with an increased risk of chronic lymphocytic lymphoma (CLL).
The differential diagnosis may include benign lymphoepithelial lesion, nonspecific sialadenitis, cystadenoma lymphomatosum papilliferum, nodal B-cell chronic lymphocytic lymphoma, mantle cell lymphoma, follicular lymphoma, and human immunodeficiency virus-related lymphadenopathy.
Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.
Purine analog-based regimens have emerged as highly active regimens in the treatment of chronic lymphocytic lymphoma (CLL).
Full browser ?